This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bristol-Myers Settles With SEC

A federal judge has signed off on a $150 million payment that Bristol-Myers Squibb (BMY - Get Report) agreed to make as part of a settlement of charges with the Securities and Exchange Commission.

It's the latest development in an Aug. 4 settlement between Bristol-Myers Squibb and the SEC concerning government investigations of accounting practices and inventory management activity that began two years ago.

The New York-based company agreed to settle a pending civil case by paying a total of $150 million, including the $100 million fine, into a shareholder compensation fund under court direction. The agreement with the SEC followed, by a few days, the company's agreement to pay $300 million to settle a shareholder class-action suit covering similar allegations.

The accounting issue involved a restatement Bristol-Myers announced more than a year ago. The company had overstated revenue between 1999 and 2001 by $2.5 billion in offering wholesalers incentives to build up their inventories -- a maneuver known as channel stuffing.

Bristol-Myers neither admitted nor denied wrongdoing in connection with the investigation, which began in April 2002. The company said it cooperated fully with the SEC and has implemented a series of internal controls and procedures designed to ensure that its financial reporting processes meet the highest standards of integrity and professionalism.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG
BMY $68.46 -0.62%
AAPL $132.80 1.10%
FB $80.99 0.63%
GOOG $541.88 -0.12%
TSLA $246.52 0.37%

Markets

DOW 18,272.36 -13.38 -0.07%
S&P 500 2,129.30 -1.52 -0.07%
NASDAQ 5,096.2420 +5.4480 0.11%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs